throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`
`Paper 47
`Date: May 16, 2022
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________________
`
`SAMSUNG ELECTRONICS CO., LTD. and
`SAMSUNG ELECTRONICS AMERICA, INC.,
`Petitioner,
`v.
`NANOCO TECHNOLOGIES LTD.,
`Patent Owner.
`
`IPR2021-00186
`Patent 8,524,365 B2
`
`
`Before ERICA A. FRANKLIN, GRACE KARAFFA OBERMANN, and
`CHRISTOPHER M. KAISER, Administrative Patent Judges.
`
`OBERMANN, Administrative Patent Judge.
`
`
`
`
`JUDGMENT
`Final Written Decision
`Determining No Challenged Claims Unpatentable
`35 U.S.C. § 318(a)
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`I. INTRODUCTION
`This is a Final Written Decision in an inter partes review of claims 1–
`
`23 of U.S. Patent No. 8,524,365 B2 (Ex. 1001, “the ’365 patent”). We have
`jurisdiction under 35 U.S.C. § 6 and enter this Decision pursuant to
`35 U.S.C. § 318(a). For the reasons that follow, we determine that
`Petitioner1 does not establish by a preponderance of the evidence that any
`challenged claim is unpatentable.
`A. Procedural History
`Petitioner filed a Petition requesting review of the challenged claims.
`Paper 1 (“Pet.”). With the Petition, Petitioner filed the Declaration of Mark
`A. Green, Ph.D., in support of the challenges stated in the Petition. Ex. 1002.
`Patent Owner2 filed a Preliminary Response to the Petition (Paper 12).
`Pursuant to our authorization, Petitioner filed a Reply (Paper 14) and Patent
`Owner filed a Sur-reply (Paper 15).
`Based on that preliminary record, we instituted an inter partes review
`of all challenged claims based on all grounds of unpatentability asserted in
`the Petition. Paper 17 (“Dec.”). The following table sets forth the grounds.3
`
`
`1 “Petitioner” refers collectively to Samsung Electronics Co., Ltd. and
`Samsung Electronics America, Inc. See Paper 38, 1 (identification of
`Petitioner’s real parties-in-interest).
`2 “Patent Owner” refers to Nanoco Technologies Ltd. Paper 6, 1. See
`Paper 6, 1 (identification of Patent Owner’s real party-in-interest).
`3 The Leahy-Smith America Invents Act (“AIA”), Pub. L. No. 112-29, 125
`Stat. 284, 287–88 (2011), amended 35 U.S.C. §§ 102 and 103, effective
`March 16, 2013. Because the ’365 patent application has an effective filing
`date prior to March 16, 2013, the pre-AIA versions of §§ 102 and 103 apply.
`
`
`2
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`
`Claims Challenged
`1, 7–12, 17, 22, 23
`1, 7–12, 15–17, 22,
`23
`2–6, 18–21
`13, 14
`1–9, 17–23
`1, 2, 4, 7–12, 17, 18,
`22, 23
`
`35 U.S.C. §
`102
`103(a)
`
`103(a)
`103(a)
`103(a)
`103(a)
`
`References
`Banin4
`Banin
`
`Banin, Herron5
`Banin, Treadway6
`Zaban,7 Farneth,8 Yu9
`Lucey,10 Ahrenkiel111
`
`
`4 Banin et al., WO 03/097904 A1, published Nov. 27, 2003 (“Banin,”
`Ex. 1005).
`5 Herron et al., Crystal Structure and Optical Properties of
`Cd32S14(SC6H5)36∙DMF4, a Cluster with a 15 Angstrom CdS Core, 259
`SCIENCE 1426–1428 (1993) (“Herron,” Ex. 1016).
`6 Treadway et al., U.S. Patent No. 6,815,064, issued Nov. 9, 2004
`(“Treadway, Ex. 1015).
`7 Zaban et al., Photosensitization of Nanoporous TiO2 Electrodes with InP
`Quantum Dots, 14 LANGMUIR 3153–3156 (1998) (“Zaban,” Ex. 1006).
`8 Farneth et al., Bulk Semiconductors from Molecular Solids: A Mechanistic
`Investigation, 4 CHEM. MATER. 916–922 (1992) (“Farneth,” Ex. 1009).
`9 Yu et al., Heterogeneous Seeded Growth: A Potentially General Synthesis
`of Monodisperse Metallic Nanoparticles, 123 J. AM. CHEM. SOC. 9198–9199
`(2001) (“Yu,” Ex. 1010).
`10 Lucey et al., US 7,193,098 B1, issued Mar. 20, 2007 (“Lucey,” Ex. 1011).
`11 Ahrenkiel et al., Synthesis and Characterization of Colloidal InP
`Quantum Rods, 3 (6) NANO LETTERS 833–837 (2003) (“Ahrenkiel,”
`Ex. 1012).
`
`
`3
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`Claims Challenged
`13–16
`
`35 U.S.C. §
`103(a)
`
`References
`Lucey, Ahrenkiel,
`Treadway
`
`After institution of trial, Patent Owner filed a Response (Paper 25,12
`“Resp.”), along with the Declaration of Brandi Cossairt, Ph.D. (Ex. 2030),
`Petitioner filed a Reply (Paper 32, “Reply”), along with the Second
`Declaration of Dr. Green (Ex. 1093), and Patent Owner filed a Sur-reply
`(Paper 39, “Sur-reply”).13 The parties presented oral arguments during a
`hearing held by video on February 23, 2022.14 Paper 46 (“Tr.”).
`B. Related Matters
`The parties identify litigation involving the ’365 patent as a related
`
`matter: Nanoco Technologies Ltd. v. Samsung Electronics Co., Ltd.,
`No. 2:20-cv-00038 (E.D. Tex.) (“District Court case”). Pet. 71; Paper 6, 1.
`The parties also identify, as related matters, petitions for review filed
`in connection with four other patents asserted in the District Court case:
`IPR2021-00182 for U.S. Patent No. 9,680,068, IPR2021-00183 for U.S.
`
`
`12 Patent Owner filed Paper 25 (unredacted Response) under seal and
`Paper 26 (redacted Response) in the public record. Thereafter, “the parties
`agreed that” the Response does “not contain confidential information and”
`does “not need to be sealed.” Paper 30, 1.
`13 Based on their respective statements of qualifications and curricula vitae,
`which are not contested, we determine that both Dr. Green and Dr. Cossairt
`are qualified to provide opinions about the knowledge and understanding of
`a person of ordinary skill in the art at the time of the invention. Ex. 1002
`¶¶ 17–30; Ex. 1003; Ex. 2030 ¶¶ 5–21, Appendix A.
`14 A consolidated hearing was conducted in IPR2021-00182, IPR2021-
`00183, IPR2021-00184, IPR2021-00185, and this proceeding, however, the
`cases are not consolidated. See Paper 43 (Order, setting oral argument).
`
`4
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`Patent No. 7,588,828 (“IPR183”), IPR2021-00184 for U.S. Patent
`No. 7,803,423, and IPR2021-00185 for U.S. Patent No. 7,867,557. Pet. 71;
`Paper 6, 1–2. Concurrently with this Decision, we enter final written
`decisions in those administrative proceedings.
`
`C. The ’365 Patent (Ex. 1001)
`The ’365 patent relates to “[a] nanoparticle comprising a molecular
`cluster compound and a core semiconductor material disposed on the
`molecular cluster compound.” Ex. 1001, 20:9–13. The semiconductor
`material, in turn, “comprises one or more elements not comprised within the
`molecular cluster compound.” Id. The nanoparticle may be prepared by a
`process that employs at least two precursor species in a nanoparticle
`precursor composition – “a first precursor species containing a first ion to be
`incorporated into the core semiconductor material and a separate second
`precursor species containing a second ion to be incorporated into the core
`semiconductor material.” Id. at 20:54–62.
`The written description states, “There has been substantial interest in
`the preparation and characterization” of compound semiconductors that
`include “particles with dimensions in the order of 2–100 [nanometers]
`(nm).” Id. at 1:21–25. That interest “mainly” may be “due to their size-
`tunable electronic, optical, and chemical properties and the need for the
`further miniaturization of both optical and electronic devices.” Id. at 1:26–
`28. The written description further indicates that such nanoparticles may be
`useful in a “range” of “commercial applications,” including “biological
`labelling, solar cells, catalysts, biological imaging, [and] light-emitting
`diodes.” Id. at 1:29–31.
`
`5
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`The written description discusses the preparation of two different
`molecular cluster compounds. Id. at 15:5–31. The description includes nine
`examples for preparing nanoparticles; eight involve a core that comprises
`cadmium and selenium, and one involves a core that comprises cadmium
`and tellurium. Id. at 15:33–19:4.
`
`D. Challenged Claims
`We reproduce below claim 1, which is the sole independent
`challenged claim and illustrates the subject matter of the invention.
` 1. A nanoparticle comprising a molecular cluster compound
`and a core semiconductor material disposed on the molecular
`cluster compound, wherein
`the semiconductor material
`comprises one or more elements not comprised within the
`molecular cluster compound.
`Ex. 1001, 20:9–13. The other challenged claims inherit the above limitations
`through direct or indirect dependence on claim 1. See id. at 31:18–56 (claims
`2–6), 32:37–54 (claims 16 and 17).
`
`II. ANALYSIS
`Our analysis is centered on explaining why we determine that
`Petitioner does not carry its burden of proving the unpatentability of claim 1
`based on any ground asserted in the Petition. Petitioner advances no
`information, in connection with any other challenged claim, that cures the
`deficiencies that we identify below in the context of claim 1. See Pet 24–42,
`49–54, 58–66. Accordingly, the challenges asserted in the Petition rise and
`fall with the sufficiency of Petitioner’s showing made as to claim 1, and our
`analysis of claim 1 applies with equal force to each challenged claim.
`
`
`
`6
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`A. Principles of Law
`To prevail in this proceeding, Petitioner must demonstrate by a
`preponderance of the evidence that the challenged claims are unpatentable.
`35 U.S.C. § 316(e); 37 C.F.R. § 42.1(d) (2019). “In an [inter partes review],
`the petitioner has the burden from the onset to show with particularity why
`the patent it challenges is unpatentable.” Harmonic Inc. v. Avid. Tech., Inc.,
`815 F.3d 1356, 1363 (Fed. Cir. 2016); see also 35 U.S.C. § 312(a)(3) (2012)
`(requiring inter partes review petitions to identify “with particularity . . . the
`evidence that supports the grounds for the challenge to each claim”). That
`burden of persuasion never shifts to Patent Owner. Dynamic Drinkware,
`LLC v. Nat’l Graphics, Inc., 800 F.3d 1375, 1378 (Fed. Cir. 2015); see also
`In re Magnum Oil Tools Int’l, Ltd., 829 F.3d 1364, 1375–78 (Fed. Cir. 2016)
`(discussing the burden of proof in inter partes review proceedings).
`A claim is unpatentable for obviousness if, to one of ordinary skill in
`the pertinent art, “the differences between the subject matter sought to be
`patented and the prior art are such that the subject matter as a whole would
`have been obvious at the time the invention was made.” 35 U.S.C. § 103(a)
`(2006); see also KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 406 (2007).
`The question of obviousness is resolved on the basis of underlying
`factual determinations including the scope and content of the prior art, any
`differences between the claimed subject matter and the prior art, the level of
`ordinary skill in the art, and objective evidence of nonobviousness.15
`
`
`15 Although Patent Owner does not expressly argue that any objective
`evidence of nonobviousness undercuts Petitioner’s challenges in this case,
`Patent Owner does assert that Petitioner tried, without success, “to solve the
`
`
`7
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`Graham v. John Deere Co., 383 U.S. 1, 17–18 (1966). “An obviousness
`determination requires finding both ‘that a skilled artisan would have been
`motivated to combine the teachings of the prior art references to achieve the
`claimed invention, and that the skilled artisan would have had a reasonable
`expectation of success in doing so.’” CRFD Research, Inc. v. Matal, 876
`F.3d 1330, 1340 (Fed. Cir. 2017) (quoting Intelligent Bio-Sys., Inc. v.
`Illumina Cambridge Ltd., 821 F.3d 1359, 1367–68 (Fed. Cir. 2016)).
`
`We analyze Petitioner’s challenges according to the above-stated principles.
`B. Person of Ordinary Skill in the Art
`The level of skill in the art is a factual determination that provides a
`primary guarantee of objectivity in an obviousness analysis. Al-Site Corp. v.
`VSI Int’l Inc., 174 F.3d 1308, 1324 (Fed. Cir. 1999) (citing Graham v. John
`Deere Co., 383 U.S. 1, 17–18 (1966); Ryko Mfg. Co. v. Nu-Star, Inc., 950
`F.2d 714, 718 (Fed. Cir. 1991)). In Petitioner’s view, an ordinarily skilled
`artisan would have had “at least a Ph.D. in chemistry, physics, chemical
`engineering, material science, or equivalent technical degree or equivalent
`work experience, with knowledge regarding nanoparticles and methods of
`synthesizing them” and “[a]dditional education might supplement practical
`
`
`problems associated with producing cadmium-free quantum dots” and,
`further, that Petitioner’s “research lead” considered “developing cadmium-
`free quantum dot technology ‘to be quite a challenge.’” Paper 12, 20
`(quoting Ex. 2005, 3). To the extent Patent Owner asserts that these factual
`contentions are secondary indicia of non-obviousness, the contentions are
`not developed adequately. Id. In any event, even if we set aside those
`contentions, for reasons explained in our analysis of the challenges, we
`determine that Petitioner fails to show by a preponderance of the evidence
`that the prior art supports a finding of obviousness.
`
`8
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`experience and vice-versa.” Pet. 20–21 (citing Ex. 1002 ¶¶ 76–75). Patent
`Owner does not address Petitioner’s view or propose a counter definition.
`We determine that the level of ordinary skill is reflected in the prior
`art of record. See Okajima v. Bourdeau, 261 F.3d 1350, 1355 (Fed. Cir.
`2001) (specific findings on the ordinary skill level are not required “where
`the prior art itself reflects an appropriate level and a need for testimony is
`not shown” (quoting Litton Indus. Prods., Inc. v. Solid State Sys. Corp., 755
`F.2d 158, 163 (Fed. Cir. 1985))). To the extent a more specific definition is
`required, we adopt Petitioner’s definition for purposes of this Decision,
`because that definition is unopposed and consistent with the disclosures of
`the asserted prior art references.
`
`C. Claim Construction
`The Board applies the same claim construction standard that would be
`used to construe the claim in a civil action under 35 U.S.C. § 282(b).
`37 C.F.R. § 42.100(b) (2020). Under that standard, claim terms “are
`generally given their ordinary and customary meaning” as understood by a
`person of ordinary skill in the art at the time of the invention. Phillips v.
`AWH Corp., 415 F.3d 1303, 1312–13 (Fed. Cir. 2005) (en banc). “In
`determining the meaning of the disputed claim limitation, we look
`principally to the intrinsic evidence of record, examining the claim language
`itself, the written description, and the prosecution history, if in evidence.”
`DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc., 469 F.3d 1005, 1014
`(Fed. Cir. 2006) (citing Phillips, 415 F.3d at 1312–17). Extrinsic evidence is
`“less significant than the intrinsic record in determining ‘the legally
`operative meaning of claim language.’” Phillips, 415 F.3d at 1317.
`
`9
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`Petitioner asserts that:
`While the full scope of the term “molecular cluster
`compound” is unclear––the ’365 patent states that the term “is
`widely understood in the relevant technical field” as relating to
`“clusters of 3 or more metal or nonmetal atoms and their
`associated ligands,” but related U.S. Patent No. 7,588,828 [at
`issue in related IPR183] “clusters of 3 or more metal atoms and
`their associated ligands”(compare Ex. 1001, 5:19–25, with
`Ex. 1054, 3:29–35)–this issue need not be resolved because the
`grounds relied on in this Petition disclose molecular cluster
`compounds with three or more metal atoms.
`Pet. 21 (footnote omitted) (Petitioner’s emphasis).
`Patent Owner responds that the written description of the invention
`provided in the ’365 patent informs:
`“Molecular cluster” is a term which is widely understood in the
`relevant technical field but for the sake of clarity should be
`understood herein to relate to clusters of 3 or more metal or
`nonmetal atoms and their associated ligands of sufficiently well
`defined chemical structure such that all molecules of the cluster
`compound possess the same relative molecular mass.
`Resp. 24. Patent Owner contends that the parties’ dispute about the scope of
`the term “molecular cluster compound” was resolved in the parallel
`litigation and “the District Court construed the term ‘molecular cluster
`compound’ to mean ‘clusters of three or more metal atoms and their
`associated ligands of sufficiently well-defined chemical structure such that
`all molecules of the cluster compound possess the same relative molecular
`formula.’” Resp. 24–25 (quoting Dec. 16 (citing Ex. 1091, 18)).
`Based on our consideration of the record as a whole, we agree with
`the District Court that the molecular cluster compound of the claimed
`invention must have “sufficiently well-defined chemical structure such that
`
`10
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`all molecules of the cluster compound possess the same relative molecular
`formula.” Ex. 1091, 18. To the extent that this or any other claim term
`requires further discussion, we provide it in our analysis of the challenges.
`No further express claim construction is necessary for purposes of this
`Decision. See Wellman, Inc. v. Eastman Chem. Co., 642 F.3d 1355, 1361
`(Fed. Cir. 2011) (“[C]laim terms need only be construed ‘to the extent
`necessary to resolve the controversy.’” (quoting Vivid Techs., Inc. v. Am.
`Sci. & Eng’g, Inc., 200 F.3d 795, 803 (Fed. Cir. 1999))).
`
`D. Overview of the Asserted Prior Art References
`1. Banin
`Banin “relates to a method for synthesizing rod-shaped semiconductor
`nanocrystals, inter alia rod-shaped Group III-V semiconductor
`nanocrystals.” Ex. 1005, 2:2–4.16 Banin describes “introducing nanoparticles
`of a metal catalyst that serve as starting nanocrystals from which nanorods
`of inorganic semiconductors grow in solution while stopping the growth to
`obtain rods.” Id. at 7:3–6. Banin discloses that “[t]he metal catalyst can be
`made, for example, of a transition metal, e.g. Zn, Cd, Mn, etc., a Group IIIa
`metal, e.g. In, Ga, Al, alloys of such metals such as for example Au-In, or
`core/shell layered metal particle.” Id. at 7:9–11.
`We reproduce below Banin’s Figure 1.
`
`
`16 We refer to original page numbers in Exhibit 1005, not page numbers
`added by Petitioner.
`
`11
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`
`
`Figure 1 illustrates the growth mechanism of indium-arsenic (“InAs”)
`nanorods for Banin’s invention. Id. at 11:11–12. Banin describes, for
`example, that “InAs nanorods were synthesized via the reaction of
`tris(trimethylsilyl)arsenine ((TMS)3As) and InCl3 in trioctylphosphine-oxide
`(TOPO), using metallic indium or gold as the catalyst.” Id. at 14:9–11. Metal
`catalyst M forms a starting nanocrystal from which a semiconductor nanorod
`grows, with the left end of the III-V semiconductor nanorod grown first and
`then moved away from the catalyst M during growth of the nanorod. Id.
`at 14:11–16.
`Banin also uses “small Au clusters (1.4 nm in mean diameter) instead
`of Au particles (2 nm in mean diameter)” and describes an experiment that
`uses “triphenylphosphine coated Au clusters with a diameter of 1.4 nm and
`the suggested formula Au101(PPh3)21Cl5” to prepare InAs rods. Id. at 21:12–
`17. Banin further discloses that its metal catalyst can be “Fe, Zn, Pd, Pt, Ni,
`Co, Mn, Ag, Cd or alloys and layered particles thereof.” Id. at claim 30.
`
`
`
`12
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`2. Herron
`Herron is a journal article describing the formation of a
`Cd32S14(SC6H5)36·DMF4 cluster from a solution of pyridine and N,N-di-
`methylformamide (DMF). Ex. 1016, 1426, Abstract. According to Herron,
`the cluster consists of an 82 atom CDS core that is approximately 12
`angstroms in diameter. Id. Herron discloses that the “cluster dissolves intact
`in tetrahydrofuran.” Id.
`Herron further describes the use of “very small molecular clusters as
`synthetic precursors to bulk, extended solids” as interesting for
`semiconductor materials and that the solubility of Herron’s cluster may be
`used in the production of polymer films having good photoconductor
`properties, “which points to a real utility for such soluble semiconductor
`clusters in the preparation of materials that go into electronic devices made
`for this and other thin-film applications.” Id. at 1426, 1428.
`3. Zaban
`Zaban is a paper titled “Photosensitization of Nanoporous TiO2
`
`Electrodes with InP Quantum Dots.” Ex. 1006, 3153. Zaban describes a
`method for synthesizing quantum dots from precursors in a solution that
`includes zinc acetate as a dopant. Id. at 3154; see Pet. 38; Reply 20
`(acknowledging that Zaban relates to a “Zn-doped” nanoparticle synthesis).
`In Zaban’s synthetic method, zinc acetate is employed as a dopant “in a
`ratio” to produced doped quantum dots of indium phosphide that “contain on
`average one Zn2+ ion per particle.” Ex. 1006, 3154.
`4. Farneth
`Farneth is a journal article regarding the mechanism of the solid-state
`conversion of II/VI precursors having the general formula
`
`13
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`(R4N+)4[S4M10(SPh)16]4-, where “(R = Me, Et; M = Cd, Zn).” Ex. 1009, 916,
`Abstract. Farneth describes heating the molecular cluster
`[(CH3)4N+]4[S4Cd10-(SPh)16]4- in an inert atmosphere to cause a first reaction
`in which 4(NMe4SPh) is lost to produce the intermediate solid Cd10S16Ph12.
`Id. at 918. A second reaction cause by the loss of S6Ph12 leaves a solid
`residue of CdS. Id. Farneth discloses that “the structural integrity of the
`clusters appears to be maintained in the solid.” Id. at 920.
`5. Yu
`Yu is a journal article that is directed to heterogeneous seeded growth
`of monodisperse metallic nanoparticles, particularly the “growth of nearly
`monodisperse Bi [bismuth], Sn [tin], and In nanoparticles of various sizes
`upon 1.5-nm Au seeds.” Ex. 1010, 9198. Yu explains that growth can be
`accomplished by decomposing the precursors Bi-[N(SiMe3)2]3, Sn(NMe2)2,
`or In(C5H5) in solutions containing Au seeds and polymers that were added
`to stabilize the nanoparticles. Id. Yu discloses thermally decomposing the Bi
`and Sn precursors at 150 and 140°C, respectively, and decomposing the In
`precursor at room temperature by adding methanol in the presence of
`poly(vinylpyrrolidinone). Id. Yu proposes a mechanism for the formation of
`the monodisperse colloid or nanoparticles by describing the growth as
`“seeded growth” in which “preformed seeds provide the nuclei for
`subsequent growth of metallic nanoparticles.” Id.
`6. Treadway, Lucey, and Ahrenkiel
`Petitioner asserts Treadway, Lucey, and Ahrenkiel in one or more
`
`grounds advanced in the Petition. Pet. 14–15. We make no findings
`pertaining to these references because none is necessary to our analysis.
`
`
`
`14
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`E. Grounds that Assert Banin
`Petitioner asserts that the subject matter of claim 1, and claims
`
`depending directly or indirectly therefrom, would have been anticipated by
`or obvious over the disclosure of Banin alone. Pet. 14. In connection with
`other dependent claims, Petitioner asserts obviousness grounds based on
`Banin in combination with Herron or Treadway. Id. at 14–15.
`We organize our analysis into five subparts, addressing, in turn, (1)
`whether Petitioner shows by a preponderance of the evidence that Banin’s
`small gold clusters are MCCs; (2) an alternative theory of unpatentability
`raised for the first time in the Reply, based on the disclosure of Banin alone,
`that an ordinarily skilled artisan would have replaced Banin’s gold clusters
`with known MCCs not identified with particularity by Petitioner; (3) the
`ground based on Banin and Herron; (4) the ground based on Banin and
`Treadway; and (5) our conclusions on the grounds that assert Banin.
`1. Whether Banin’s “small Au clusters” are MCCs
`Our analysis focuses on the claim 1 limitation that requires “[a]
`nanoparticle comprising a molecular cluster compound.” Ex. 1001, 20:9–13.
`Our analysis of independent claim 1 applies with equal force to each of the
`other challenged claims, because each depends directly or indirectly from
`claim 1 and, thereby, inherits the limitation requiring a molecular cluster
`compound (“MCC”). Id. at 20:9–21:18 (claims).
`Petitioner asserts that Banin discloses small gold clusters that are
`MCCs. Pet. 22. For reasons that follow, we find Petitioner does not show
`persuasively that Banin’s “small Au clusters” (also referred to herein as
`Banin’s “Au-based clusters,” “gold clusters,” “gold cluster catalysts,” and
`“metal catalysts”) are MCCs.
`
`15
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`For reasons explained in our claim construction analysis, we apply the
`construction assigned by the District Court, under which MCCs are “clusters
`of three or more metal atoms and their associated ligands of sufficiently
`well-defined chemical structure such that all molecules of the cluster
`compound possess approximately the same relative molecular formula.”
`Ex. 1091, 18. According to Petitioner, Banin’s Au-based clusters are MCCs.
`Pet. 22–23; Ex. 1002 ¶ 90. To support that position, Petitioner directs us to
`Banin’s disclosure that the Au-based clusters have “the suggested formula
`Au101(PPh3)21Cl5” (Ex. 1005, 20:12–16) and the testimony of Dr. Green
`(Ex. 1002 ¶ 90). Pet. 22–23.
`Dr. Green testifies, “It is my opinion that a [person of ordinary skill in
`the art] would have understood that the gold clusters Au101(PPh3)21Cl5” in
`Banin’s process “are ‘clusters of 3 or more metal’ atoms (i.e., because the
`other atoms of the clusters, (PPh3)21Cl5, are the ligands), and their associated
`ligands’ and that each cluster is ‘identical to one another.’” Ex. 1002 ¶ 90
`(citing Ex. 1001, 5–25; Ex. 1005, 20:12–16). Dr. Green continues, “That is
`supported by Banin’s disclosure that the Au clusters ‘provid[e] large seeds
`for rapid InAs [nanoparticle] growth.’” Id. (citing Ex. 1005, 23:24–27).
`Dr. Green considers the gold clusters to have a “sufficiently well-defined
`chemical structure such that all molecules of the cluster compound possess
`approximately the same relative molecular formula” because each cluster is
`identical and promotes Banin’s seeded synthetic reaction. At the petition
`stage, that is essentially the extent of Petitioner’s and Dr. Green’s
`explanation for their view that Banin’s gold clusters are MCCs. Pet. 22–23.
`Patent Owner counterargues that Banin “does not disclose [an] MCC.”
`Resp. 25; see Ex. 2030 ¶¶ 99–131 (Dr. Cossairt’s opinions, and citations to
`
`16
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`supporting evidence, explaining why Banin’s gold clusters are not MCCs).
`According to Patent Owner, Banin’s gold clusters “do not have a sufficiently
`well-defined chemical structure such that all molecules of the cluster
`compound possess the same relative molecular formula,” as required for
`MCCs. Resp. 25. On that point, Patent Owner states that Banin does not
`describe its gold clusters as “identical to one another,” as Petitioner contends
`and, further, “Petitioner points to the formula Au101(PPh3)21Cl5,” which
`“Banin itself describes as “merely a ‘suggested formula.’” Id. at 27 (citing
`Ex. 1005, 20:13–16; Ex. 2030 ¶¶ 101–102; Pet. 22). In Patent Owner’s view,
`Banin’s clusters range in size, and “different sizes are averaged out” to
`estimate “that the average number of gold atoms is approximately 101.” Id.
`at 28 (citing Ex. 2017, 12891; Ex. 2030 ¶¶ 107–108).
`
`A preponderance of the evidence supports Patent Owner’s position.
`Compare Ex. 1002 ¶ 90 (Dr. Green’s testimony and cited evidence), with
`Ex. 2030 ¶¶ 99–131 (Dr. Cossairt’s testimony and cited evidence). Banin
`discloses that the Au clusters are “synthesized by the published procedures”
`in Hutchison.17 Resp. 27–28; Ex. 1005, 2:25–26, 20:13–16; Ex. 2030
`¶¶ 105–110. As Dr. Cossairt points out, the gold cluster catalysts in Banin’s
`process are not well-defined and the molecular formula Au101(PPh3)21Cl5 is
`assigned based on a calculation that relies on the average of a range of
`particle sizes that result from the method of Hutchison. Ex. 2030 ¶¶ 106–
`108, 111 (citing Ex. 2017, 12891). Based on Dr. Cossairt’s comprehensive
`
`
`17 Weare et al., Improved Synthesis of Small (dCORE ≈ 1.5nm)Phosphine-
`Stabilized Gold Nanoparticles, 122 J. A J. AM. CHEM. SOC. 12890–12891
`(2000) (“Hutchison,” Ex. 2017).
`
`17
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`examination of Hutchison’s disclosure and other supporting evidence, Patent
`Owner provides detailed reasons why the clusters that Banin prepares
`according to Hutchison’s process do not qualify as MCCs within the scope
`of claim 1. Ex. 2030 ¶¶ 99–131; Resp. 27–37.
`Specifically, referring to Hutchison Figure 1(a), reproduced below,
`Dr. Cossairt testifies, “The Hutchison process creates gold particle
`agglomerations of many different sizes.” Ex. 2030 ¶ 106.
`
`
`Ex. 2017, 12891, Fig. 1(a). Dr. Cossairt testifies that Hutchison’s Figure 1(a)
`“is a transmission electron microscopy [TEM] image along with an
`imbedded histogram that shows the size distribution of the gold particles.”
`Ex. 2030 ¶ 106. She also testifies that this figure shows, and the histogram
`confirms with its variety of differently sized black dots, that the sizes of the
`gold clusters prepared by Hutchison’s process vary by “a size difference
`ranging from at least 1.0–2.25 nm.” Id.
`
`18
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`
`Dr. Cossairt further testifies that “Hutchison describes the gold
`clusters as ‘narrowly disperse’ nanoparticles 1.5 nm ±0.4 nm in diameter.”
`Id. ¶ 107 (citing Ex. 2017, 12890). In Dr. Cossairt’s view, “What this really
`means is that on average, there is a distribution of sizes from around 1.1–1.9
`nm, but as the histogram of” Hutchison’s Figure 1(a), reproduced above,
`“shows, the overall size variation is much broader.” Id. “Despite that broad
`mix of sizes,” Dr. Cossairt explains, “Hutchison attempted to assign a
`molecular weight formula to the synthesized gold clusters.” Id.
`Dr. Cossairt points out, “As Hutchison explains, Au101(PPh3)21Cl3 is
`‘an average molecular formula’ that was ‘estimated’ in order to assign a
`formula based off of the average 1.5 nm particle size” observed in
`Hutchison’s synthesized clusters. Id. (quoting Ex. 2017, 12891)
`(Dr. Cossairt’s emphasis). Additionally, as Dr. Cossairt observes, Hutchison
`uses the tilde symbol, “~”, when referring to the estimated particle size,
`namely, “~101,” which indicates that the disclosed particle size of 101 is
`only an “approximate formula for an average-sized particle.” Id. ¶ 113. In
`other words, both Banin and Hutchison assign a “suggested” value of 101 to
`the gold in the clusters. Compare Ex. 1005, 2:25–26, 20:13–16 (Banin,
`assigning a “suggested” formula to the gold clusters), with Ex. 2017, 12891
`(Hutchison, assigning the same “estimated” formula as Banin to the gold
`clusters). In Dr. Cossairt’s view, an ordinarily skilled artisan “would not
`confuse assumptions and estimates with a well-defined chemical structure,
`particularly where the data points used to generate that assumption are so
`widely varied.” Ex. 2030 ¶ 109.
`Dr. Cossairt asserts that Hutchison’s Figure 1(a) shows that gold
`clusters prepared according to its process do not “have the same molecular
`
`19
`
`

`

`IPR2021-00186
`Patent 8,524,365 B2
`
`mass.” Id. ¶ 106 (quoting Ex. 2017, 12890). Dr. Cossairt states, “A
`dispersity that varies by 25% is not considered monodisperse in the art.” Id.
`¶ 118 (citing Ex. 1001, 5:28–29). Dr. Cossairt testifies that an ordinarily
`skilled artisan “would understand that the claimed [MCC] would, at the very
`least, need to be able to be chemically characterized,” that Banin does not
`“actually chemically characterize the gold clusters produced by the
`Hutchison process,” and that both “references cite and rely upon an average
`gold droplet size that is then itself used to generate a suggested formula
`without actually characterizing any observed particles.” Id. ¶ 111.
`Dr. Cossairt testifies further, by using “gold particles that are not
`sufficiently well-defined,” Banin’s process cannot achieve the stated goal of
`the ’365 patent, which is to make “a population of nanoparticles that is
`essentially monodisperse.” Id. ¶ 118 (citing Ex. 1001, 5:28–29). Dr. Cossairt
`directs us to disclosures within the four corners of Banin, which indicate that
`“the diameter of the nanorods is dictated by the size of the gold particle” and
`that the diameter of Banin’s “nanorods can vary by up to 25%,” just like the
`gold particles do. Id.; Ex. 1005, 15:2–4, 23:17–18; Ex. 2017,

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket